mergers & acquisitions Feb 23, 2023 Jounce Therapeutics to Merge With Redx After Laying Off 57 Percent of Workforce Feb 21, 2023 Aileron Therapeutics Nixes Chemoprotective Trial of ALRN-6924 in p53-Mutated Breast Cancer Feb 14, 2023 Fusion Pharmaceuticals to Acquire Prostate Cancer Radiopharmaceutical Program From RadioMedix Feb 6, 2023 Isoray, Viewpoint Molecular Targeting Complete Merger to Advance Targeted Radiopharmaceuticals Jan 25, 2023 Indivumed Sells Biospecimens Service Unit to CRO Crown Bioscience Jan 17, 2023 Leap Therapeutics Merges With Flame Biosciences to Advance Several Precision Oncology Drugs Jan 17, 2023 Elicio Therapeutics to Merge With Angion Biomedica Dec 20, 2022 Gilead Sciences to Acquire Cell Therapy Biotech Tmunity Therapeutics Dec 20, 2022 Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M Nov 29, 2022 AstraZeneca to Acquire Cell Therapy Firm Neogene Therapeutics Nov 22, 2022 Biocare Medical Acquires Empire Genomics Oct 20, 2022 Ayala Pharmaceuticals, Advaxis Announce Merger With Refocused Precision Oncology Pipeline Premium Oct 20, 2022 AUM Biosciences to Go Public via Merger With Mountain Crest Acquisition Oct 18, 2022 Avacta to Acquire Dx Distributor Launch Diagnostics for up to £37M Oct 14, 2022 Enliven Therapeutics, Imara Merge to Advance Precision Oncology Pipeline Sep 7, 2022 Roche to Acquire Good Therapeutics for $250M Aug 2, 2022 MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M Jun 27, 2022 Ipsen Acquires Epizyme, Garners Tazverik, Other Oncology Assets Jun 3, 2022 BMS to Acquire Turning Point Therapeutics in Deal Valued at $4.1B May 12, 2022 Taiho Pharmaceutical Acquires Cullinan Pearl, Regaining Rights to EGFR Inhibitor Load More Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma